Bill · H.R. 5094· House(119-HR-5094)
Protect Patients from Costly Care Act
- Introduced
- 9/2/2025
- Last activity
- 9/2/2025 — Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- Sponsored by
- Chris Pappas
- Cosponsors
- - 9 - 0
- Introduced
- In Committee
What this bill would do
This bill is called the Protect Patients from Costly Care Act. It aims to roll back recent changes made to Medicaid cost sharing requirements. It also undoes changes related to the exclusion for orphan drugs under the Medicare Drug Price Negotiation Program. By doing this, the legislation puts things back the way they were before those specific changes were made. We need to hold our elected officials accountable to ensure these legislative actions truly protect everyday people.
Yes· 3 of 23
Would households on low incomes be better off under this?+7
Low-income households rely heavily on Medicaid and directly benefit from repealed cost-sharing increases.
Would people with disabilities be better off under this?+6
Individuals with disabilities frequently rely on Medicaid and orphan drugs, making the rollbacks beneficial.
Does this put more money into Medicaid, the health coverage for people on low incomes?+6
The bill repeals changes to Medicaid cost-sharing requirements, protecting low-income beneficiaries from increased out-of-pocket costs.
The opposite
No question was scored the opposite.
Who it would affect, and how
Potential Positive Impacts for People
-
Medicaid Cost Sharing Protection: Under Section 2, the bill repeals previous changes to Medicaid cost sharing requirements and rescinds related appropriations. This could be seen as positive because it puts the rules back to how they were, protecting people who rely on Medicaid from those specific cost-sharing changes.
-
Orphan Drug Protections: Under Section 3, the bill repeals changes made to the exclusion for orphan drugs under the Medicare Drug Price Negotiation Program. This is a positive step for individuals who depend on these specific drugs, as it restores the prior rules governing the program.
Potential Negative Impacts for People
- Rescission of Funds: Under Section 2(b), the bill rescinds the amounts previously appropriated under section 71120(c) of Public Law 119-21. While the text simply removes this funding, it means those specific appropriated funds will no longer be available, which could be viewed as a negative outcome depending on how those funds were intended to be used.
Groups and Interests Ranking
Every group the model scored this bill for, from -10 to +10. Hover a score for the reason it gave.
- Demographic And Interest Groups
- Good For Low Income Households+7Good For People With Disabilities+6Good For Retirees+5Good For Seniors+5Good For Children+4Good For African Americans+3Good For Hispanic Americans+3Good For Middle Aged+3Good For Women+3Good For Young Adults+3Good For Immigrants+2Good For Men+2Good For Middle Class Households+2Good For Native Americans+2Good For Rural Residents+2Good For Urban Residents+2Good For Asian Americans+1Good For L G B T Q Community+1Good For Students+1Good For White Americans+1
- Healthcare
- Increases Medicaid Funding+6Improves Healthcare Access+5Reduces Prescription Drug Costs+5
- 9/2/2025
- Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- 9 Cosponsors added.
- Introduced in House
One bill Congress.gov lists as related to this one — companions in the other chamber, earlier versions, and bills this one absorbed or was folded into.
André CarsonDemocrat · Indiana
Angie CraigDemocrat · Minnesota
Cleo FieldsDemocrat · Louisiana
Maggie GoodlanderDemocrat · New Hampshire
Jonathan JacksonDemocrat · Illinois
John LarsonDemocrat · Connecticut
Eleanor NortonDemocrat · District of Columbia
Raul RuizDemocrat · California
Shri ThanedarDemocrat · Michigan